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Introduction
Left ventricular assist devices (LVADs) are an estab-
lished therapeutic strategy in patients with end-stage 
heart failure. LVADs require continuous triple anti-
coagulation (AC) to prevent thromboembolic complica-
tions and device clotting.1 Even though a significant 
improvement in functional status has been shown, the 
clinical course can be long. A known complication of 
long-term hospitalization is sacral pressure sores (SPS), 
which contribute to pain, infectious complications and 
increased risk of death.3 As previously shown, invasive 
type 3 and 4 SPS are best treated surgically.4 To prevent 
fecal contamination, the placement of a diverting ileos-
tomy (DI) usually precedes reconstructive surgery.
Case Description
A 54-year-old male underwent LVAD (HeartWare®, 
International Inc., Framingham, MA) implantation as a 
bridge to transplant for severe ischemic cardiomyopathy 
with prolonged hospitalization. Five by eight by ten cen-
timeter stage IV SPS developed. Five months after LVAD 
implantation, the clinical situation was stable and the 
single limiting issue remained the SPS (Figure 1).
Warfarin and clopidogrel were discontinued and a 
heparin drip with the goal of a partial thromboplastin 
time (PTT) of 60-80 seconds was initiated. Aspirin 
(ASA) 100 mgs daily was continued. Uncomplicated 
laparoscopic DI placement was performed without sig-
nificant blood loss despite continuation of the heparin 
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drip. General anesthesia (GA) was tolerated well with-
out hemodynamic instability. On postoperative day 
(POD) 3, the patient suffered small bowel obstruction 
(SBO), resistant to conservative measures, which 
prompted emergent take-back to the OR on POD 6. 
Exploratory laparoscopy had to be converted to median 
laparotomy due to extensive diffuse bleeding and poor 
visibility. Small bowel loops appeared twisted around 
the ileostomy, which was then disconnected and rein-
serted. Diffuse oozing prolonged surgery, but stopped 
after the PTT was kept at 60-70 sec and several units of 
packed red blood cells (PRBC) had been transfused. 
Fresh frozen plasma and protamine were avoided due to 
the fear of the LVAD clotting. The abdomen was closed 
and recovery was uneventful, with proper DI function. 
Later, non-infectious diarrhea caused severe metabolic 
acidosis and volume loss. In addition, patient suffered 
deterioration of chronic kidney disease, becoming 
dependent on hemofiltration.
On POD 23, excision of the SPS, debridement and 
coccygectomy were performed in the prone position with 
GA and on a heparin drip and ASA. Extensive diffuse 
bleeding prompted the transfusion of 4 PRBC and pack-
ing of the wound with resolvable hemostyptica and surgi-
cal pads rather than vacuum sponge therapy. The bleeding 
eventually stopped, with strict control of the PTT at 60-70 
sec and local pressure. At this point, ASA was discontin-
ued. On POD 27, ipsilateral VY-FCF surgery was per-
formed, significant for extensive diffuse bleeding, 
requiring the substitution of 2 units of PRBC, placement 
of an extra drain and several strips of resolvable hemostyp-
tica underneath the flap. A small hematoma resolved with 
conservative management, the wounds healed properly 
(Figure 2) and ASA was restarted.
Four weeks later, the LVAD flow suddenly dropped to 
1.5 L/min. A computed tomography (CT) scan revealed 
thrombosis of the LVAD outflow cannula. Thrombolysis 
with tirofiban remained unsuccessful and severe 
epistaxis limited further attempts. Deteriorating hemo-
dynamics required endostent placement into the out-
flow cannula and the LVAD flow immediately came 
back to 3.5 L/min. The day after, two 2-cm wound 
defects (Figure 3) of the FCF, with spontaneous dis-
charge of fresh, non-infected hematoma occurred, 
which was managed conservatively. Eventually, the 
patient suffered a major intracerebral hemorrhage and 
expired.
Discussion
With an increasing number of patients receiving 
LVADs, the need for surgical procedures on support 
systems is increasing. Guidelines for perioperative 
management haven’t yet been established. A previous 
study identified major postoperative bleeding as the 
main problem in smaller procedures, such as cholecys-
tectomy, appendectomy and tracheostomy, where 
heparin was held perioperatively without clotting com-
plications.6 Another study claimed that patients with 
Figure 2. Fasciocutaneous flap.
Figure 3. Wound dehiscence.
Figure 1. Sacral pressure sore preoperatively.
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LVADs tolerated smaller procedures with perioperative 
discontinuation of AC with tolerable thromboembolic 
risk.7 Contrary to these cases with favorable outcomes, 
Ficke et al. describe a patient with LVAD, who under-
went an uneventful cystoscopy, but, shortly thereafter, 
went into cardiac arrest with fatal outcome.8
The challenge in our case was the need for consecu-
tive major surgical procedures. We chose perioperative 
continuation of heparin and ASA to avoid thromboem-
bolic events in acceptance of increased intra- and post-
operative bleeding. The strict PTT range of 60-80 sec 
was insufficient and clotting occurred as a late compli-
cation. During a period of severe hemorrhagic compli-
cations, ASA had to be withheld and was then not 
continued, which might have contributed. We decided 
on pro fecal diversion to avoid contamination and pro-
mote wound healing, even if this added a procedure, 
risking further complications. For reconstruction, an 
ipsilateral VY-FCF was chosen over a musculocutane-
ous flap to limit bleeding. The soft tissue defect occurred 
unusually late and seems likely related to local pressure 
during lying supine on the unpadded angiography table. 
Fatal intracranial bleeding occurred weeks after the 
intervention and seems independent.
Concluding
With the size of the SPS faced, conservative manage-
ment would unlikely have resulted in satisfactory SPS 
healing. Surgical intervention was needed, but caused 
myriad subsequent complications. From our experi-
ence, it is imperative to continue heparinization and 
ASA during major surgery in patients with LVADs as 
life-threatening LVAD clotting can occur. Therefore, in 
these fragile patients, the benefit of intervention has to 
outweigh the risk of bleeding, which should be managed 
with meticulous surgical technique and substitution of 
PRBC rather than the reversal of heparinization or the 
substitution of clotting factors. Continuation or, at least, 
the early resumption of double anti-platelet therapy 
should also be considered
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